IS THE ORPHANAGE FILLING UP? PROJECTING THE GROWTH AND BUDGET IMPACT OF ORPHAN DRUGS IN EUROPE

被引：4
|
作者：
Flostrand, S. [1 ]
Rodriguez, I [2 ]
Maddox, B. [3 ]
Finch, L. [3 ]
Belulaj, S. [3 ]
Gould, A. [4 ]
机构：
[1] IMS Consulting Grp, Paris, France
[2] IMS Consulting Grp, Madrid, Spain
[3] IMS Consulting Grp, Cambridge, England
[4] Univ Cambridge, Cambridge, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1454
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY137
引用
收藏
页码：A599 / A599
页数：1
相关论文
共 28 条
  • [21] Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US
    Padula, William V.
    Parasrampuria, Sonal
    Socal, Mariana P.
    Conti, Rena M.
    Anderson, Gerard F.
    PHARMACOECONOMICS, 2020, 38 (10) : 1115 - 1121
  • [22] Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"
    Manning, Richard
    PHARMACOECONOMICS, 2020, 38 (12) : 1373 - 1374
  • [23] Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”
    William V. Padula
    Sonal Parasrampuria
    Mariana P. Socal
    Rena M. Conti
    Gerard F. Anderson
    PharmacoEconomics, 2020, 38 : 1375 - 1376
  • [24] Reply to Comment on "Market Exclusivity for Drugs with Multiple Orphan Approvals (1983-2017) and Associated Budget Impact in the US"
    Padula, William V.
    Parasrampuria, Sonal
    Socal, Mariana P.
    Conti, Rena M.
    Anderson, Gerard F.
    PHARMACOECONOMICS, 2020, 38 (12) : 1375 - 1376
  • [25] DRUGS FOR RARE (AND ULTRA-RARE) DISEASES IN EUROPE: ANALYSIS OF BUDGET IMPACT AND COST DRIVERS
    Schlander, M.
    Stenner, K.
    Gandjour, A.
    VALUE IN HEALTH, 2016, 19 (07) : A598 - A598
  • [26] BUDGET IMPACT ANALYSIS OF DRUGS FOR ULTRA-RARE NON-ONCOLOGICAL DISEASES IN EUROPE
    Schlander, M.
    Gandjour, A.
    VALUE IN HEALTH, 2014, 17 (07) : A525 - A525
  • [27] Patient Accessibility and Budget Impact of Orphan Drugs in South Korea: Long-Term and Real-World Data Analysis (2007-2019)
    Lee, Se Hee
    Yoo, Seung-Lai
    Bang, Joon Seok
    Lee, Jong Hyuk
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (09)
  • [28] SEVERE ULCERATIVE COLLITIS IN CHILDREN AND ADOLESCENTS IN POLAND -IT'S TIME TO CATCH UP WITH EUROPE. BUDGET IMPACT ANALYSIS (BIA) FOR BIOSIMILAR INFLIXIMAB
    Borowiack, E.
    Borowiack, M.
    Garbacka, M.
    Kedziora, Kowalska M.
    Nowotarska, A.
    Raczynska, G.
    Bukowinska, K.
    Klejman, M.
    VALUE IN HEALTH, 2016, 19 (07) : A581 - A581
123